-
1
-
-
17444452702
-
Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma
-
Gunduz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999;117:609-614.
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 609-614
-
-
Gunduz, K.1
Shields, C.L.2
Shields, J.A.3
-
2
-
-
0026662028
-
Radiation maculopathy after proton beam irradiation for choroidal melanoma
-
Guyer DR, Mukai S, Egan KM, et al. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 1992;99:1278-1285.
-
(1992)
Ophthalmology
, vol.99
, pp. 1278-1285
-
-
Guyer, D.R.1
Mukai, S.2
Egan, K.M.3
-
4
-
-
0025429219
-
Maculopathy caused by irradiation in patients treated for choroid melanoma
-
Haye C, Desjardins L, Bouder P, et al. Maculopathy caused by irradiation in patients treated for choroid melanoma. Ophtalmologie 1990;4:229-231.
-
(1990)
Ophtalmologie
, vol.4
, pp. 229-231
-
-
Haye, C.1
Desjardins, L.2
Bouder, P.3
-
5
-
-
0031765762
-
The efficacy of focal laser therapy in radiation-induced macular edema
-
Hykin PG, Shields CL, Shields JA, Arevalo JF. The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 1998;105:1425-1429.
-
(1998)
Ophthalmology
, vol.105
, pp. 1425-1429
-
-
Hykin, P.G.1
Shields, C.L.2
Shields, J.A.3
Arevalo, J.F.4
-
6
-
-
22744440013
-
Photodynamic therapy for maculopathy due to radiation retinopathy
-
Bakri SJ, Beer PM. Photodynamic therapy for maculopathy due to radiation retinopathy. Eye 2005;19:795-799.
-
(2005)
Eye
, vol.19
, pp. 795-799
-
-
Bakri, S.J.1
Beer, P.M.2
-
7
-
-
0034786579
-
Radiation retinopathy: The role of pentoxifylline
-
Gupta P, Meisenberg B, Amin P, Pomeranz H. Radiation retinopathy: the role of pentoxifylline. Retina 2001;21:545-547.
-
(2001)
Retina
, vol.21
, pp. 545-547
-
-
Gupta, P.1
Meisenberg, B.2
Amin, P.3
Pomeranz, H.4
-
8
-
-
0031050126
-
Increased expression of angiogenic growth factors in age-related maculopathy
-
Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997;81:154-162.
-
(1997)
Br J Ophthalmol
, vol.81
, pp. 154-162
-
-
Kliffen, M.1
Sharma, H.S.2
Mooy, C.M.3
-
9
-
-
33644502828
-
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
-
Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.
-
(2006)
Ophthalmology
, vol.113
, pp. 363-372
-
-
Avery, R.L.1
Pieramici, D.J.2
Rabena, M.D.3
-
10
-
-
23044505200
-
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration
-
Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335.
-
(2005)
Ophthalmic Surg Lasers Imaging
, vol.36
, pp. 331-335
-
-
Rosenfeld, P.J.1
Moshfeghi, A.A.2
Puliafito, C.A.3
-
11
-
-
33646446084
-
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study
-
Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284.
-
(2006)
Retina
, vol.26
, pp. 279-284
-
-
Iturralde, D.1
Spaide, R.F.2
Meyerle, C.B.3
-
12
-
-
33845745774
-
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
-
Haritglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
-
(2006)
Retina
, vol.26
, pp. 999-1005
-
-
Haritglou, C.1
Kook, D.2
Neubauer, A.3
-
13
-
-
33646443430
-
Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema
-
Mason J, Albert M, Vail RC. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 2006;26:356-357.
-
(2006)
Retina
, vol.26
, pp. 356-357
-
-
Mason, J.1
Albert, M.2
Vail, R.C.3
-
14
-
-
33846362539
-
Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy
-
Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol; 2007;143:335-338.
-
(2007)
Am J Ophthalmol
, vol.143
, pp. 335-338
-
-
Finger, P.T.1
-
15
-
-
20144368709
-
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration
-
Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 2005;112:1048-1053.
-
(2005)
Ophthalmology
, vol.112
, pp. 1048-1053
-
-
Rosenfeld, P.J.1
Schwartz, S.D.2
Blumenkranz, M.S.3
-
16
-
-
34248598513
-
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
-
Peters S, Heiduschka P, Julien S, et al. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 2007;143:995-1002.
-
(2007)
Am J Ophthalmol
, vol.143
, pp. 995-1002
-
-
Peters, S.1
Heiduschka, P.2
Julien, S.3
-
17
-
-
0031737671
-
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group
-
Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-1959.
-
(1998)
Diabetes
, vol.47
, pp. 1953-1959
-
-
Antonetti, D.A.1
Barber, A.J.2
Khin, S.3
-
18
-
-
33947313405
-
VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability
-
Harhaj NS, Felinski EA, Wolepert EB, et al. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 2006;47:5106-5115.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, pp. 5106-5115
-
-
Harhaj, N.S.1
Felinski, E.A.2
Wolepert, E.B.3
-
19
-
-
34748830341
-
Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma
-
Mason 3rd, JO Albert Jr, MA Persaud TO, Vail RS. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina 2007;27:903-907.
-
(2007)
Retina
, vol.27
, pp. 903-907
-
-
Mason 3rd, J.O.1
Albert Jr, M.A.2
Persaud, T.O.3
Vail, R.S.4
|